Clincosm LogoSign in Get a demo

AML

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

Active, not recruiting
  • AML
  • Flotetuzumab dose escalation
  • +2 more
  • Duarte, California
  • +42 more
Mar 7, 2022

Severe Infections on Acute Myeloid Leukemia (AML) Patients

Recruiting
  • AML
  • Adult
  • Observation
  • Civitanova Marche, Ancona, Italy
  • +45 more
Dec 31, 2021

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
Has Results
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

Italian Non-Interventional Study of FLT3 Mutated AML Patients

Unknown status
  • AML
  • +2 more
  • Clinical and Molecular data collection
  • Ancona, AN, Italy
  • +32 more
Apr 20, 2020

Hematologic Malignancies, AML Trial in Worldwide (CP-4055)

Completed
  • Hematologic Malignancies
  • AML
  • Valhalla, New York
  • +15 more
Sep 12, 2013